V029-2001 Screening compound: (2E)-3-phenyl-N-(propan-2-yl)-N-{2-[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}prop-2-enamide

V029-2001 Screening compound: (2E)-3-phenyl-N-(propan-2-yl)-N-{2-[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}prop-2-enamide
V029-2001 Screening compound: (2E)-3-phenyl-N-(propan-2-yl)-N-{2-[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}prop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-2001
(2E)-3-phenyl-N-(propan-2-yl)-N-{2-[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}prop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-2001

Molecular Formula

C25H29N3O5 (C25 H29 N3 O5)

Compound Name

(2E)-3-phenyl-N-(propan-2-yl)-N-{2-[3-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazol-5-yl]ethyl}prop-2-enamide

IUPAC name

(2E)-3-phenyl-N-(propan-2-yl)-N-{2-[3-(345-trimethoxyphenyl)-124-oxadiazol-5-yl]ethyl}prop-2-enamide

SMILES

CC(C)N(CCc1nc(-c(cc2OC)cc(OC)c2OC)no1)C(/C=C/c1ccccc1)=O

InChI

InChI=1S/C25H29N3O5/c1-17(2)28(23(29)12-11-18-9-7-6-8-10-18)14-13-22-26-25(27-33-22)19-15-20(30-3)24(32-5)21(16-19)31-4/h6-12,15-17H,13-14H2,1-5H3

InChI Key

PCPVDWZWOPXHSJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19778250

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

451.52

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.626

Distribution Coefficient, logD

4.626

Water Solubility, LogSw

-4.44

Polar Surface Area

69.965

Acid Dissociation Constant (pKa)

26.73

Base Dissociation Constant (pKb)

3.35

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

V029-2001 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

KRAS-Targeted Library (16000 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V029-2001 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-2001?
Check Price and Availability of V029-2001, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-2001 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-2001
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-2001
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-2001 available by request